Cargando…
L1 Cell Adhesion Molecule Promotes Migration and Invasion via JNK Activation in Extrahepatic Cholangiocarcinoma Cells with Activating KRAS Mutation
Extrahepatic cholangiocarcinoma (ECC), a malignant tumor of biliary origin, has a poor prognosis with limited treatment options. The KRAS oncogene is the most commonly mutated gene in ECC and one of the factors that predicts a poor prognosis and low survival rate. L1 cell adhesion molecule (L1CAM) i...
Autores principales: | Kim, Haejung, Hwang, Haein, Lee, Hansoo, Hong, Hyo Jeong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Molecular and Cellular Biology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5463045/ https://www.ncbi.nlm.nih.gov/pubmed/28535665 http://dx.doi.org/10.14348/molcells.2017.2282 |
Ejemplares similares
-
Combination of anti-L1 cell adhesion molecule antibody and gemcitabine or cisplatin improves the therapeutic response of intrahepatic cholangiocarcinoma
por: Cho, Seulki, et al.
Publicado: (2017) -
CCR7 Mediates Cell Invasion and Migration in Extrahepatic Cholangiocarcinoma by Inducing Epithelial–Mesenchymal Transition
por: Oba, Mitsunobu, et al.
Publicado: (2023) -
BUB1B promotes extrahepatic cholangiocarcinoma progression via JNK/c-Jun pathways
por: Jiao, Chen Yu, et al.
Publicado: (2021) -
Novel insights into the intraepithelial spread of extrahepatic cholangiocarcinoma: clinicopathological study of 382 cases on extrahepatic cholangiocarcinoma
por: Nagashima, Daisuke, et al.
Publicado: (2023) -
Quantitative proteomic analysis of bile in extrahepatic cholangiocarcinoma patients
por: Son, Kuk Hui, et al.
Publicado: (2020)